Ftse Mib
34.938,90
0,45%
DAX
20.340,57
0,65%
S&P 500
5.909,03
-1,11%
NASDAQ
19.489,68
-1,89%
Bitcoin
96.224,07
-0,70%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Abivax SA (ABVX) Abivax SA (ABVX) Notizie

Abivax SA

ABVX
6,98
-0,29 (-3,99%)
08 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/12/202423:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/12/202422:05GLOBEAbivax Announces a Change to the Composition of its Board of..
27/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
19/11/202422:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/11/202422:30GLOBEAbivax Establishes an At-the-Market (ATM) Program on Nasdaq
19/11/202422:02EDGAR2Form F-3 - Registration statement by foreign private issuers
14/11/202422:01GLOBEAbivax presents third quarter 2024 key financial information
14/11/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202422:01GLOBEAbivax Announces Former Prometheus COO, Mark Stenhouse,..
07/10/202422:01GLOBEAbivax Congratulates Victor Ambros and Gary Ruvkun on Their..
03/10/202422:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/10/202422:01GLOBEAbivax Announces First Patient Enrolled in ENHANCE-CD, the..
03/10/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/10/202408:31GLOBEAbivax Reports Positive Interim Efficacy and Safety Analysis..
26/9/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/9/202408:30GLOBEAbivax to Present Three Abstracts for Obefazimod in..
25/9/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/9/202422:01GLOBEAbivax Provides Update on Ulcerative Colitis (UC)..
09/9/202422:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/9/202422:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/9/202422:01GLOBEAbivax presents first-half 2024 financial results
09/9/202412:09IHMARKETNEWSU.S. Futures Rise Amid Inflation Report Anticipation; Oil..
06/8/202408:30GLOBEAbivax Announces ABTECT Phase 3 Trial Achieves Key..
15/7/202422:00GLOBEAbivax Provides Operational and Key Program Update
04/6/202422:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/6/202422:10GLOBEAbivax releases the results of its May 30, 2024 Ordinary and..
07/5/202422:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: 7,33 Min: 6,88 Max: 7,43
Chiusura: 7,27

La tua Cronologia

NASDAQ
ABVX
Abivax
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network